Zebrafish Disease Models: Supporting Drug Discovery and Toxicology

Oct 10, 2022

New York City, New York Oct 10, 2022 (Issuewire.com) - Zebrafish platform, the mature division of Creative Biogene, is a biotech institute specializing in zebrafish services under Good Laboratory Practice. Based on high technical expertise and top-class research facilities, Creative Biogene is dedicated to developing and validating cost-effective gene editing services, toxicity, and efficacy assays, as well as zebrafish disease models that can be used in preclinical stages. Recently, Creative Biogene announced the release of its zebrafish disease models which can support drug discovery and toxicology, and accelerate the research in therapeutic/disease areas.

Creative Biogene has established a wide range of working zebrafish models to support multiple therapeutic/disease areas. Our zebrafish model provides insights into human disease pathogenesis and associated drug discovery and toxicology and allows the evaluation of novel small molecule inhibitors. Creative Biogene has used various methods to model human genetic diseases in zebrafish.

Creative Biogene has established more than 50 genetically engineered zebrafish human cancer models that closely resemble their human counterparts at the histological and/or genomic level. Zebrafish cancer models accelerate the discovery of new mechanisms driving human cancer and identify new drugs for clinical trials. The vast majority of human tumors can be modeled in zebrafish using a combination of chemotherapy, genetic techniques, and tumor cell xenotransplantation.

Creative Biogene has established a series of zebrafish diabetes models, including induced zebrafish diabetes models, targeted gene ablation zebrafish diabetes models, transgenic zebrafish diabetes models, and mutant zebrafish diabetes, models. Creative Biogene's rich and diverse zebrafish diabetes model provides special advantages for the study of metabolic diseases and is committed to improving the understanding of the pathogenesis of diabetes through this model and providing new targets for diabetes treatment.

In addition, Creative Biogene has developed a series of zebrafish models to study obesity, including food-induced zebrafish obesity models, transgenic zebrafish obesity models, and mutant zebrafish obesity models. Creative Biogene's zebrafish model has very high utility in mechanistic studies of obesity and lipid metabolism, drug testing, and drug discovery, aiming to help discover the anti-obesity activity of drug candidates.

Creative Biogene can provide customized zebrafish uremic model construction services to monitor the effects of various compounds on zebrafish uremic models. The zebrafish model can be divided into eight diseases, including sphingolipidosis, mucolipidosis, neuronal ceroid lipofuscinosis, integral membrane proteinopathy, glycogen storage disease, glycoproteins, mucopolysaccharide deposition disorders, and lysosome-related organelle disorders.

"We have applied CRISPR/Cas9 system as the preferred tool for generating zebrafish stable models of human genetic diseases." said Marcia Brady, the marketing director of Creative Biogene, she also added, "Our services can help you predict the safety of new compounds during drug development, and the results provide the basis for internal decision-making."

About Creative Biogene
Creative Biogene is a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools, and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.

Media Contact

Marcia Brady


[email protected]

6313868241

Shirley, NY 11967, USA

https://www.creative-biogene.com/

Source :Creative Biogene

This article was originally published by IssueWire. Read the original article here.

More News

article.head.headline
Oct 15, 2026
Why cling to zero-sum thinking in the age of AI?

Why cling to zero-sum thinking in the age of AI?

article.head.headline
Oct 15, 2026
Anthropic flags revenue surge to investors ahead of stock market debut

It comes as some investors have become concerned about the amount of money being spent on AI infrastructure.

article.head.headline
Oct 15, 2026
Langflow's Critical Authenticated RCE Flaw Targeted in 1,423 Honeypot Exploit Attempts

Threat actors are exploiting a critical security flaw in Langflow, according to an alert from Previdian. Langflow is an open-source platform that allows developers to build artificial intelligence (AI) applications and agentic workflows. In February 2025, DataStax, the parent company of Langflow, was acquired by IBM. The vulnerability in question is CVE-2026-105740 (CVSS score: 9.9), a case of

article.head.headline
Oct 15, 2026
Incoming calls to show caller names from November 1: What mobile users need to know

India will roll out mandatory Calling Name Presentation (CNAP) from November 1, 2026, displaying callers' names alongside phone numbers on 4G and 5G networks. Here's how the new caller ID system will work, its privacy safeguards and rules for businesses using registered names.

article.head.headline
Oct 15, 2026
AhsayCBS Flaws Exploited to Deploy Web Shells Get New Fixes After Incomplete Patches

Singapore-based Ahsay Backup has released security updates to address two security flaws in AhsayCBS that have been exploited by bad actors to drop web shells and XMRig cryptocurrency miners. The vulnerabilities in question are CVE-2026-105133 and CVE-2026-105134, which could be chained to sidestep authentication and execute arbitrary commands on affected systems. In a report published earlier

article.head.headline
Oct 15, 2026
ASML explores capacity expansion beyond 30% increase for 2028

Dutch semiconductor equipment maker ASML said on Wednesday that it is exploring ways to expand production capacity beyond the previously announced 30% increase planned for 2028.

article.head.headline
Oct 15, 2026
China’s CXMT gets pledge of support as provincial party chief vows chip-industry expansion

Three weeks into his tenure as the Communist Party secretary of Anhui province, Li Lecheng carried out an on-site inspection at China’s home-grown memory chip giant ChangXin Memory Technologies (CXMT) on Wednesday, pledging to grow integrated circuits (ICs) as an emerging pillar industry. During the visit to the company’s headquarters in the central province’s capital of Hefei, Li urged CXMT to further refine its product portfolio and actively expand into domestic and overseas markets. He...

article.head.headline
Oct 15, 2026
Palo Alto Networks Patches PAN-OS Authenticated RCE Flaw Amid Active Exploitation

Palo Alto Networks on Wednesday issued security updates for a high-severity flaw in PAN-OS software that has come under active exploitation. The vulnerability, tracked as CVE-2026-0322 (CVSS score: 8.6), is a case of remote code execution in the management interface. "A remote code execution (RCE) vulnerability in the management interface of Palo Alto Networks PAN-OS software enables an

article.head.headline
Oct 15, 2026
FLÆ Robotics raises over €1 million in seed funding to develop and expand its AI hospitality agent

FLÆ Robotics, the Czech technology company behind BE-A, an AI hospitality agent, has raised over €1 million in seed funding from Purple Ventures and Garage Angels. BE-A is already used by more than 60 hotels across the United Kingdom, Germany and the Czech Republic. The company will use the investment to accelerate product development, deepen integrations with hotel systems, grow its team and expand internationally. FLÆ Robotics is strengthening its presence in Germany, expanding into Austria and building on its launch in the United Kingdom. It is also preparing to enter the U.S. hotel market.

article.head.headline
Oct 15, 2026
Ecommpay adds Klarna, giving consumers a more flexible way to pay

Ecommpay, the inclusive global payments platform, has added Klarna, the everyday finance network, to its payment choices, giving merchants a simple way to offer millions of shoppers greater choice, transparency and control at checkout.

article.head.headline
Oct 15, 2026
Start-up unveils prototype ‘heart’ of EUV lithography amid China chipmaking push

A Chinese start-up has unveiled a prototype extreme ultraviolet (EUV) light-source machine – a component often described as the “heart” of advanced lithography systems – marking an early but critical step in Beijing’s drive for self-reliance in chipmaking equipment. At the China International Industry Fair in Shanghai, Langdao Silex displayed its self-developed EUV light-source system. Ninety per cent of the machine’s components were localised, with the vast majority of core parts developed...

article.head.headline
Oct 15, 2026
AI job losses set to rein in office demand in developed Asia-Pacific economies: report

A mild displacement of jobs across the Asia-Pacific region as companies expand their use of AI would trim five percentage points off growth in office space demand in the next few years, according to property consultancy CBRE. In a report released on Thursday it said 3.9 per cent of office jobs were vulnerable to artificial intelligence-driven displacement in developed markets in the region, including Hong Kong, Singapore, Japan, South Korea, Taiwan, Australia and New Zealand. However, only 1.7...


YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Science Of The World

Science Of The World offers breaking in-depth news about the latest scientific discoveries and technologies in a user-friendly format.

NEWSLETTER